Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Single Blind, Randomized Controlled Trial of Virucidal Effect of Polyvinyl Pyrrol-Iodine on SARS-CoV-2 as Well as Safety of Its Application on Nasopharynx & Oropharynx of COVID-19 Positive Patients

NCT04872686 is registered in ClinicalTrials.gov with DR. MALA KHAN as lead sponsor.

NCT NCT04872686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04872686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Single Blind, Randomized Controlled Trial of Virucidal Effect of Polyvinyl Pyrrol-Iodine on SARS-CoV-2 as Well as Safety of Its Application on Nasopharynx & Oropharynx of COVID-19 Positive Patients
Lead sponsor
DR. MALA KHAN
Phase
Phase 3
Overall status
Completed
Start date
April 10, 2021
Completion date
May 30, 2021
Enrollment
798 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

effect of drug, efficacy, self, virus infection, rna